Search clinical trials for: Placebo (oral semaglutide)

Total 59410 results

Novo Nordisk A/S

Completed

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity (SELECT)

Obesity | Overweight

United States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
Novo Nordisk A/S

Active, not recruiting

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

Early Alzheimer´s Disease

Canada, United States, Taiwan, Netherlands, United Kingdom, Spain, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, China, Poland, Denmark, Czechia, Ireland, Japan, South Africa, Romania, S... and more
Novo Nordisk A/S

Active, not recruiting

A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)

Diabetes Mellitus, Type 2

Spain, United States, India, Czechia, Canada, Latvia, United Kingdom, Portugal, Serbia, Poland, Romania, Brazil, Russian Federation, Slovakia, Bulgaria, Mexico, Germany, Greece, Israel
Anders Fink-Jensen, MD, DMSci

Recruiting

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Schizophrenia | Type 2 Diabetes | Metabolic Disturbance | Clozapine | Olanzapine | GLP-1

Denmark
Novo Nordisk A/S

Recruiting

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice

Diabetes Mellitus, Type 2

Mexico
Fundación Instituto de Estudios de Ciencias de...

Not yet recruiting

Effect Of Semaglutide In Coronary Atheroma Plaque (SEPLA)

Atheroscleroses, Coronary
Novo Nordisk A/S

Enrolling by invitation

A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice (PIONEER REAL)

Diabetes Mellitus, Type 2

France
Novo Nordisk A/S

Completed

Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects

Healthy | Diabetes

Netherlands
Novo Nordisk A/S

Completed

Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Germany
Novo Nordisk A/S

Completed

A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Canada, Poland, South Africa, Slovakia
Novo Nordisk A/S

Completed

A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose

Diabetes Mellitus, Type 2 | Healthy Participants

United States
Novo Nordisk A/S

Completed

A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity

Healthy Volunteers Diabetes Mellitus, Type 2 | Healthy Volunteers Overweight | Healthy Volunteers Obesity

Netherlands
Novo Nordisk A/S

Terminated

A Research Study to Compare Two Forms of Semaglutide in Two Different Pen-injectors in People With Overweight or Obesity

Obesity | Overweight

Germany
Novo Nordisk A/S

Recruiting

A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight

Obesity or Overweight

Taiwan, Japan
Vanderbilt University Medical Center

Recruiting

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab (GLP-TEP)

Type 1 Diabetes

United States
Axel Brandes
Hillerod Hospital, Denmark; Herlev and Gentofte Hospital; Svendborg Hospital; Hospital...

Withdrawn

Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients (SOCRATES-AF)

Atrial Fibrillation | Overweight and Obesity
Novo Nordisk A/S

Completed

A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide

Healthy Volunteers (Diabetes Mellitus, Type 2)

United Kingdom
Novo Nordisk A/S

Not yet recruiting

Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea

Diabetes Mellitus, Type 2
Gan and Lee Pharmaceuticals, USA

Active, not recruiting

A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes

China
Novo Nordisk A/S

Completed

Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects

Healthy | Diabetes

United Kingdom
Novo Nordisk A/S

Completed

A Research Study to Look at Similarity Between Semaglutide Versions in Different Injection Tools

Diabetes Mellitus, Type 2

Germany
Novo Nordisk A/S

Not yet recruiting

Special Use - Results Surveillance on Long-term Use With Wegovy®

Obesity

Japan
Novo Nordisk A/S

Completed

A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men

Diabetes Mellitus, Type 2

China
AstraZeneca

Completed

A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus

Chronic Kidney Diseases | Type 2 Diabetes Mellitus

Spain, United Kingdom, New Zealand, Australia, Canada, Poland, Germany, Japan
University of Colorado, Denver
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)

Alcohol Use Disorder

United States
Novo Nordisk A/S

Completed

A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause

Diabetes Mellitus, Type 2

Germany
Huashan Hospital

Not yet recruiting

Comparison of Body Weight Change Through Different Smeglutide Administration Methods

Weight Change, Body

China
Novo Nordisk A/S

Completed

A Research Study to Compare Two Different Forms of Once-weekly Semaglutide in Two Different Injection Pens

Obesity | Overweight

Germany
Virginia Commonwealth University
Novo Nordisk A/S

Recruiting

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NAFLD

United States
Vanderbilt University Medical Center
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3) (GATA-3)

Asthma

United States
Rutgers, The State University of New Jersey
Alzheimer's Association

Recruiting

COMMETS- Combination MCI Metabolic Syndrome

Metabolic Syndrome | Alzheimer Disease | Mild Cognitive Impairment

Israel
University of Pennsylvania

Recruiting

Feasibility of Semaglutide in Advanced Lung Disease

Obesity | Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension | Interstitial Lung Disease | Sarcoidosis, Pulmonary

United States
Novo Nordisk A/S

Active, not recruiting

A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants

Healthy Participants

United States, Canada
Amir Moheet
Cystic Fibrosis Foundation

Recruiting

Semaglutide in CFRD

Cystic Fibrosis | Cystic Fibrosis-related Diabetes

United States
Geisinger Clinic

Terminated

Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy (RAISE-KT)

Obesity | Diabetic Kidney Disease | Type 2 Diabetes Mellitus in Obese | CKD | Severe Obesity

United States
Lundquist Institute for Biomedical Innovation at...

Completed

Semaglutide Treatment On Coronary Progression (STOP)

Coronary Artery Disease | Type 2 Diabetes

United States
Royan Institute

Unknown

The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women

Infertility

Iran, Islamic Republic of
VA Office of Research and Development

Active, not recruiting

Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation

Suicidal Ideation

United States
Evelo Biosciences, Inc.

Completed

A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Psoriasis | Atopic Dermatitis

United Kingdom
Sao Thai Duong Joint Stock Company
Big Leap Clinical Research Joint Stock Company

Completed

Safety and Efficacy of KOVIR in the Combination Regimen With Background Treatment in COVID-19 Patients (KOVIR) (KOVIR)

COVID-19

Vietnam
Eidos Therapeutics, a BridgeBio company

Withdrawn

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy

United States
University of Oxford
NIHR Oxford Health Biomedical Research Centre

Not yet recruiting

Semaglutide and Cognition in Healthy Volunteers (OxSENSE)

Cognitive Change

United Kingdom
Pulmagen Therapeutics

Completed

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma

Atopic Asthma

United Kingdom
University of Colorado, Denver
Novo Nordisk A/S

Recruiting

Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB) (SIB)

Type 2 Diabetes | Chronic Inflammation | Intestinal Permeability

United States
Qilu Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

Type 2 Diabetes

China
Georgetown University
National Institutes of Health (NIH)

Recruiting

Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies

Dementia With Lewy Bodies

United States
Aarhus University Hospital
Odense University Hospital; Rigshospitalet, Denmark; Bispebjerg Hospital; Herning... and other collaborators

Recruiting

Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke (ASSET)

Acute Ischemic Stroke

Denmark

Search clinical trials for: Placebo (oral semaglutide)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations